Humana (HUM) Price Target Raised to $130 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts HUM Hot Sheet
Price: $378.88 --0%
Rating Summary:
15 Buy, 19 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 57
Rating Summary:
15 Buy, 19 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 57
Join SI Premium – FREE
Cantor Fitzgerald reiterated a Buy rating on Humana (NYSE: HUM) and raised its price target to $130.00 (from $105.00).
Analyst Joseph D. France said, "We are introducing our 2015 earnings estimates, raising our price target to $130 from $105, and reiterating our BUY rating on Humana, which we believe is the most leveraged play on Medicare Advantage in the managed care group. HUM is a widely followed stock, and our earnings estimates are slightly below the FactSet consensus in both 2014 and 2015, but we see upside potential in our numbers once we get final Medicare Advantage rates for 2015 (April 7) and the company reports 1Q:14 results on May 7. There is obviously some risk in emphasizing Humana in advance of these developments, which could be less positive than we anticipate, but whatever happens next quarter, we believe that the stock is a compelling secular story."
For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.
Shares of Humana closed at $112.93 yesterday.
Analyst Joseph D. France said, "We are introducing our 2015 earnings estimates, raising our price target to $130 from $105, and reiterating our BUY rating on Humana, which we believe is the most leveraged play on Medicare Advantage in the managed care group. HUM is a widely followed stock, and our earnings estimates are slightly below the FactSet consensus in both 2014 and 2015, but we see upside potential in our numbers once we get final Medicare Advantage rates for 2015 (April 7) and the company reports 1Q:14 results on May 7. There is obviously some risk in emphasizing Humana in advance of these developments, which could be less positive than we anticipate, but whatever happens next quarter, we believe that the stock is a compelling secular story."
For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.
Shares of Humana closed at $112.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) PT Raised to $450 at Wolfe Research
- BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
- Guggenheim Reiterates Buy Rating on Rubrik Inc (RBRK)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Cantor Fitzgerald, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
